Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014)

Sarepta Therapeutics' (SRPT) quarterly Depreciation and Depletion came in at $400000.0 in Q1 2014, up 33.33% year-on-year from $300000.0 in Q1 2013, and up 33.33% quarter-over-quarter from $300000.0 in Q1 2013.

Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014) Analysis & Trends

Sarepta Therapeutics' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $400000.0 for Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Sarepta Therapeutics 1.69 Bn 1.28 Bn 622.04 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2014 400,000.00
Mar 31, 2014 400,000.00
Mar 31, 2013 300,000.00
Mar 31, 2013 300,000.00